Allmed Middle East, a UK-backed medical manufacturing company, officially launched its fourth production line for dialysis filters in Egypt with an annual capacity of 10 million units. It also inaugurated a new facility for producing dialysis solutions capable of producing 40 million litres per year. The initiative aligns with Egypt's Vision 2030 and the authority's efforts to support vital industries and boost local manufacturing to meet domestic demand and expand exports. Allmed said it exports to more than 40 countries and the expansion would raise its production capacity by 30 per cent. The project was funded by €16 million in direct investment from its UK-based parent company, reflecting growing foreign investor confidence in the Egyptian pharmaceutical market. Head of the Egyptian Drug Authority (EDA) Ali El Ghamrawy highlighted the strategic importance of producing dialysis-related products locally, describing them as essential to the national healthcare system. He underscored the EDA's commitment to supporting projects that reduce import dependence and enhance Egypt's standing as a regional hub for medical manufacturing through effective public-private collaboration. Attribution: Amwal Al Ghad English Subediting: M. S. Salama
